The Seipel Group Pty Ltd., an Australian company committed to the research and development of specialized formulations to improve bladder control, has been granted U.S. Patent No. 9,452,191 for Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder.
Seipel Group has registered the U.S. trademark Urox for the formula, a proprietary blend of Lindera aggregata, Equisetum arvense and Cratevox (Crateva nurvala), which is sold by several U.S. supplement companies under their own brands.
Developed by Tracey Seipel, N.D., a naturopathic clinician and herbalist who has been combining traditional and scientific theories to develop treatment strategies and formulations since 1987, the Urox formula was developed through years of research into the prevalence and impact of bladder control issues for both men and women, which affects up to 50 million Americans.
For more information, visit www.seipelgroup.com.au.